Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.730 | 2.740 | 0.010 |
Stocks | 97.220 | 97.220 | 0.000 |
Bonds | 0.050 | 0.090 | 0.040 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.466 | 20.001 |
Price to Book | 3.894 | 4.086 |
Price to Sales | 3.892 | 2.440 |
Price to Cash Flow | 18.556 | 16.387 |
Dividend Yield | 1.415 | 1.366 |
5 Years Earnings Growth | 15.525 | 12.512 |
Number of long holdings: 60
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 6.23 | 811.08 | -1.48% | |
Thermo Fisher Scientific | US8835561023 | 4.89 | 597.75 | -1.48% | |
J&J | US4781601046 | 4.07 | 152.15 | -0.47% | |
Novartis | CH0012005267 | 3.99 | 95.58 | +1.90% | |
Sanofi | FR0000120578 | 3.41 | 104.40 | +0.75% | |
AbbVie | US00287Y1091 | 3.29 | 183.90 | +4.70% | |
Novo Nordisk B | DK0062498333 | 3.26 | 607.3 | +0.60% | |
UnitedHealth | US91324P1021 | 2.97 | 542.49 | -0.56% | |
IQVIA Holdings | US46266C1053 | 2.84 | 201.36 | -0.21% | |
Lonza Group | CH0013841017 | 2.74 | 582.00 | -1.49% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
FR0013073731 | 736.92M | 3.11 | -0.33 | 5.97 | ||
FR0013446812 | 132.41M | -22.69 | -18.59 | - | ||
FR0013083656 | 43.54M | 0.26 | -4.55 | 4.43 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review